1,961
Views
27
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Cancer survivors’ preference for follow-up care providers: a cross-sectional study from the population-based PROFILES-registry

, , , , , , , , , , , , , , , , , , & show all
Pages 278-287 | Received 15 Aug 2016, Accepted 16 Nov 2016, Published online: 09 Jan 2017

References

  • Roorda C, Berendsen AJ, Haverkamp M, et al. Discharge of breast cancer patients to primary care at the end of hospital follow-up: a cross-sectional survey. Eur J Cancer. 2013;49:1836–1844.
  • Cheung WY, Aziz N, Noone AM, et al. Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists. J Cancer Surviv. 2013;7:343–354.
  • Greenfield DM, Absolom K, Eiser C, et al. Follow-up care for cancer survivors: the views of clinicians. Br J Cancer. 2009;101:568–574.
  • Health Council of The Netherlands. Nacontrole in de oncologie. The Hague: Health Council of The Netherlands; 2007.
  • Dutch Cancer Society. Nazorg bij kanker: de rol van de eerste lijn. Amsterdam: Dutch Cancer Society; 2011.
  • Del Giudice ME, Grunfeld E, Harvey BJ, et al. Primary care physicians' views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27:3338–3345.
  • Howell D, Hack TF, Oliver TK, et al. Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence. J Cancer Surviv. 2012;6:359–371.
  • de Leeuw J, Larsson M. Nurse-led follow-up care for cancer patients: what is known and what is needed. Support Care Cancer. 2013;21:2643–2649.
  • Lewis R, Neal RD, Williams NH, et al. Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review. J Adv Nurs. 2009;65:706–723.
  • Lewis RA, Neal RD, Williams NH, et al. Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract. 2009;59:e234–e247.
  • Roorda C, de Bock GH, Scholing C, et al. Patients' preferences for post-treatment breast cancer follow-up in primary care vs. secondary care: a qualitative study. Health Expect. 2014;18:2192–2201.
  • Anvik T, Holtedahl KA, Mikalsen H. “When patients have cancer, they stop seeing me” – the role of the general practitioner in early follow-up of patients with cancer – a qualitative study. BMC Fam Pract. 2006;7:1–9.
  • Hudson SV, Miller SM, Hemler J, et al. Adult cancer survivors discuss follow-up in primary care: 'not what I want, but maybe what I need'. Ann Fam Med. 2012;10:418–427.
  • Christen S, Vetsch J, Mader L, Dehler S, Korol D, Kuehni C, Rueegg CS, Michel G. Preferences for the organization of long-term follow-up in adolescent and young adult cancer survivors. Support Care Cancer. 2016;24:3425–3436.
  • Bender JL, Wiljer D, Sawka AM, et al. Thyroid cancer survivors' perceptions of survivorship care follow-up options: a cross-sectional, mixed-methods survey. Support Care Cancer. 2016;24:2007–2015.
  • Absolom K, Eiser C, Michel G, et al. Follow-up care for cancer survivors: views of the younger adult. Br J Cancer. 2009;101:561–567.
  • Michel G, Greenfield DM, Absolom K, et al. Follow-up care after childhood cancer: survivors' expectations and preferences for care. Eur J Cancer. 2009;45:1616–1623.
  • Neuman HB, Weiss JM, Schrag D, et al. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013;20:4128–4136.
  • Integraal Kankercentrum Nederland. Prostaatcarcinoom: Landelijke richtlijn, Versie: 2.0. Utrecht: 2014. Available from: http://www.oncoline.nl.
  • Oncoline. Detectie nieuwe kankermanifestaties. 2012 [cited 2016 June 13]. Available from: http://www.oncoline.nl/melanoom.
  • Sangha O, Stucki G, Liang MH, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheumat. 2003;49:156–163.
  • Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.
  • Zimet GD, Dahlem NW, Zimet SG, et al. The multidimensional scale of perceived social support. J Pers Asses. 1988;52:30–41.
  • Crespi CM, Ganz PA, Petersen L, et al. Refinement and psychometric evaluation of the impact of cancer scale. J Pers Asses. 2008;100:1530–1541.
  • Vermunt JK, Magidson J. Latent GOLD 4.0 User's Guide. Belmont (MA): Statistical Innovations Inc; 2005.
  • Jung HP, Baerveldt C, Olesen F, et al. Patient characteristics as predictors of primary health care preferences: a systematic literature analysis. Health Expect. 2003;6:160–181.
  • Roorda C, Berendsen AJ, Groenhof F, et al. Increased primary healthcare utilisation among women with a history of breast cancer. Support Care Cancer. 2013;21:941–949.
  • Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–718.